Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Orbicella faveolata, Whole Genome Sequencing from USVI

PROVIDER: PRJNA634780 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11844100_1.fastq.gz	Fastqsanger.gz
	SRR11844100_2.fastq.gz	Fastqsanger.gz
	SRR11844101_1.fastq.gz	Fastqsanger.gz
	SRR11844101_2.fastq.gz	Fastqsanger.gz
	SRR11844055_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 94

Similar Datasets

Orbicella faveolata

Project description:Orbicella faveolata Genome sequencing

| PRJNA970355 | ENA

Orbicella faveolata

Project description:Orbicella faveolata WPD holotranscriptome sequencing

| PRJNA289876 | ENA

Project description:Metagenomes from Orbicella faveolata

| PRJNA925892 | ENA

Orbicella faveolata isolate:FL

Project description:Orbicella faveolata isolate:FL Genome sequencing and assembly

| PRJNA378841 | ENA

Orbicella faveolata

Project description:Orbicella faveolata Phenotype or Genotype

| PRJNA397198 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Fast Lesion Progression in Orbicella faveolata

| PRJNA1120359 | ENA

Orbicella faveolata

Project description:Orbicella faveolata Transcriptome or Gene expression

| PRJNA586570 | ENA

Orbicella faveolata strain:S16

Project description:Orbicella faveolata strain:S16 Raw sequence reads

| PRJNA380651 | ENA

Proteomic Investigation of Factors Driving Resistance and/or Resilience to Stony Coral Tissue Loss Disease

Project description:Florida’s coral reefs are currently experiencing a multi-year disease-related mortality event, that has resulted in massive die-offs in multiple coral species. Coral monitoring data and disease prevention/treatment efforts from recent years have identified individual Orbicella faveolata that possess high, moderate, or low resistance to stony coral tissue loss disease (SCTLD). Ninety samples of high, moderate, or low SCTLD resistance were collected from 3 reefs for bottom-up LC-MS/MS analysis (n=30 for each resistance category).

2022-01-13 | PXD030923 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data